This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Wuhan Institute of Virology, Cas. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Xin-Wen Chen
Introduction
Xin-Wen Chen is a prominent inventor based in Wuhan, China. He has made significant contributions to the field of biomedical research, particularly in the development of transgenic models for studying viral infections. His work is crucial for advancing our understanding of hepatitis C virus (HCV) infections.
Latest Patents
Xin-Wen Chen holds 1 patent related to his innovative research. The patent describes a CD81 and OCLN double transgenic mouse and its construction method and use. This double transgenic mouse model is designed to facilitate the study of both acute and chronic HCV infections, providing valuable insights into the disease mechanisms.
Career Highlights
Chen is affiliated with the Wuhan Institute of Virology, a leading research institution in China. His work at this institute has positioned him as a key figure in the field of virology, contributing to the development of new models for studying viral infections.
Collaborations
Throughout his career, Xin-Wen Chen has collaborated with notable colleagues, including Hong Tang and Ji-Zheng Chen. These collaborations have enhanced the scope and impact of his research, fostering advancements in the understanding of viral pathogenesis.
Conclusion
Xin-Wen Chen's innovative work in developing transgenic mouse models represents a significant advancement in the study of hepatitis C virus infections. His contributions continue to influence the field of virology and biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile